Related Experiment Video
Updated: Jul 26, 2026

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)
Published on: September 13, 2018
Parents' experience with positive newborn screening results for cystic fibrosis
Inken Brockow1, Uta Nennstiel2
1Screening Center, Bavarian Health and Food Safety Authority (LGL), Veterinaerstrasse 2, 85764, Oberschleissheim, Germany. Inken.brockow@lgl.bayern.de.
Insights
Parents prefer direct communication from cystic fibrosis (CF) specialists after positive newborn screening results. Shorter delays and clear information from CF centers reduce parental stress and improve satisfaction.
Area of Science:
- Medical Screening
- Pediatric Health
- Genetics
Background:
- Newborn screening for cystic fibrosis (CF) in Germany since 2016 raises concerns about psychological harm from false positives.
- Parental stress is a significant factor in the screening process, particularly following positive results.
Purpose of the Study:
- To investigate parental perceptions of the CF screening process in Bavaria.
- To evaluate the communication strategies following positive CF screening results and their impact on parental satisfaction and diagnostic timelines.
Main Methods:
- A questionnaire was administered to families in Bavaria who underwent diagnostic testing after a positive CF screening result.
- Data collected from 105 families (54.7% response rate) focused on information sources, satisfaction with communication, and time delays to diagnosis.
Main Results:
- Only 30 parents received mandatory physician information about newborn screening; direct communication from CF specialists (28.6%) led to higher satisfaction (80% vs. 50%) and shorter diagnostic delays.
- A delay of over 3 days between screening notification and diagnostic testing was considered too long by 77.7% of families.
Conclusions:
- Timely diagnostic testing and satisfactory information are crucial for reducing parental stress.
- Informing parents directly by CF centers about positive results, coinciding with imminent sweat testing, is recommended to improve the screening experience.
Abstract:
In Germany, screening for cystic fibrosis (CF) is part of the newborn screening since September 2016. The risk of psychological harm due to false-positive screening results is a longstanding concern. We investigated the parents' perception of the CF screening process in Bavaria and the communication after positive screening results with a questionnaire. Until August 2018, 192 children went through a final diagnostic testing after a positive CF screening result, and 105 (54.7%) families completed the questionnaire. Of these, only 30 parents obtained information about the newborn screening by a physician, despite this being mandatory in Germany. Parents being informed by a CF specialist (28.6%) about the positive screening result were more satisfied with the given information (80.0 versus 50% informed by the maternity ward), and the delay until the final diagnostic testing was shorter. More than 3 days between the information about the screening result and the diagnostic testing was too long for 77.7% of the families.Conclusion: Performing final diagnostic testing with only short delays and receiving satisfactory information is important. Therefore, parents should be informed directly by a CF center about positive screening results and only when sweat testing is possible within the next days. What is Known: • The risk of psychological harm due to false-positive screening results is a longstanding concern. • Satisfactory information about the positive CF screening result seem to reduce the parental stress. What is New: • Parents being informed directly by a CF specialist were more satisfied with the given information and the delay until the final diagnostic testing was shorter. • Our data support the concept that parents should better be informed directly by a CF specialist about positive screening results and only when sweat testing is possible within the next days to reduce parental stress.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...